Literature DB >> 24556143

Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors.

Da-Hua Shi1, Wei Huang2, Chao Li2, Yu-Wei Liu3, Shi-Fan Wang4.   

Abstract

A series of aloe-emodin derivatives were synthesized and evaluated as xanthine oxidase inhibitors. Among them, four aloe-emodin derivatives showed significant inhibitory activities against xanthine oxidase. The compound 4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-carbaldehyde (A1) possessed the best xanthine oxidase inhibitory activity with IC50 of 2.79 μM. Lineweaver-Burk plot analysis revealed that A1 acted as a mixed-type inhibitor for xanthine oxidase. The docking study revealed that the molecule A1 had strong interactions with the active site of xanthine oxidase and this result was in agreement with kinetic study. Consequently, compound A1 is a new-type candidate for further development for the treatment of gout.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aloe-emodin; Gout; Inhibitor; Xanthine oxidase

Mesh:

Substances:

Year:  2014        PMID: 24556143     DOI: 10.1016/j.ejmech.2014.01.058

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

Review 1.  Mechanistic insights into xanthine oxidoreductase from development studies of candidate drugs to treat hyperuricemia and gout.

Authors:  Takeshi Nishino; Ken Okamoto
Journal:  J Biol Inorg Chem       Date:  2014-12-12       Impact factor: 3.358

2.  Identification of xanthine oxidase inhibitors through hierarchical virtual screening.

Authors:  Ying Yang; Lei Zhang; Jinying Tian; Fei Ye; Zhiyan Xiao
Journal:  RSC Adv       Date:  2020-07-24       Impact factor: 4.036

3.  Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.

Authors:  Guddeti Dileep Kumar; Bandi Siva; Sravanthi Vadlamudi; Surendar Reddy Bathula; Hashnu Dutta; K Suresh Babu
Journal:  RSC Med Chem       Date:  2021-04-26

4.  Cleroda-4(18),13-dien-15,16-olide as novel xanthine oxidase inhibitors: An integrated in silico and in vitro study.

Authors:  Ha Thi Nguyen; Thien-Y Vu; Tikam Chand Dakal; Bhanupriya Dhabhai; Xuan Hong Quan Nguyen; Vinay Bharadwaj Tatipamula
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

Review 5.  Hyperuricemia-Related Diseases and Xanthine Oxidoreductase (XOR) Inhibitors: An Overview.

Authors:  Changyi Chen; Jian-Ming Lü; Qizhi Yao
Journal:  Med Sci Monit       Date:  2016-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.